General Information of the Compound
Compound ID
CP0526001
Compound Name
3-[1-(2-Chloro-phenyl)-meth-(E)-ylidene]-2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-(9Z)-ylideneamine
    Show/Hide
Structure
Formula
C18H14ClN3
Molecular Weight
307.784
Canonical SMILES
Clc1ccccc1\C=C1/CCn2c1nc1ccccc1c2=N
    Show/Hide
InChI
InChI=1S/C18H14ClN3/c19-15-7-3-1-5-12(15)11-13-9-10-22-17(20)14-6-2-4-8-16(14)21-18(13)22/h1-8,11,20H,9-10H2/b13-11+,20-17?
    Show/Hide
InChIKey
ATYIDQJDFITBDK-NOYHUVOJSA-N
Physicochemical Property
logP
4.11347
Rotatable Bonds
1
Heavy Atom Count
22
Polar Areas
41.67
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44391247
ChEMBL ID
CHEMBL361761
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01215, C-C chemokine receptor type 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000002 K-562 Homo sapiens (Human)  1
1
Ki = 35 nM
   TI
   LI
   LO
   TS